CClinicalTrials.gg
CompletedNCT02871180Updated Aug 18, 2016

Late Night Snack and Insulin Glargine

An interventional study of Late night snack and No late night snack in Type 1 Diabetes and Hypoglycemia, sponsored by Diabeteszentrum Bad Lauterberg im Harz. Completed at 1 site in Germany. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2016-08-18.

Sponsored by Diabeteszentrum Bad Lauterberg im Harz · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Twenty patient with Type 1 diabetes, using insulin glargine as basal insulin, participated in a prospective, controlled crossover trial comparing blood glucose profiles over two 24 h periods with and without a late night snack (a slice of rye bread, 20 g carbohydrates, at 10 p.m.), in randomized order. The main endpoint was the number of hypoglycemic episodes with a confirmed laboratory blood glucose ≤ 50 mg/dl between 10 p.m. and 8 p.m. the following day. Secondary endpoint was the blood glucose profile during this period.

Read the detailed description

The order of studies (with and without a late night snack) was determined by randomization. Study-related procedures started at 6 p.m. (standard blood glucose profiles with determinations at 6, 8, and 10 p.m, at midnight, at 2, 4, 6:45, 8:45 a.m., and at noon and 2, 6, and 8 p.m. of the following day). At 10 p.m. a late night snack (one slice of whole meal rye bread containing approximately 20 g of carbohydrate) was eaten or no nutrients were consumed, as determined by the randomization protocol. After one day without study-related activities, the study was repeated with the complementary protocol (crossover design). Patients were instructed to use fast-acting insulin to correct hyperglycemia three times per day (before major meals) or to take in additional carbohydrate when symptomatic or chemical hypoglycemia was noted. They were asked not to perform strenuous exercise beyond their normal daily activities.

02

Conditions studied

  • Type 1 Diabetes
  • Hypoglycemia

Keywords

  • Hypoglycemia
  • Type 1 diabetes
03

In context

Diabetes Mellitus, Type 1

3,522 studies on the registry are indexed under Diabetes Mellitus, Type 1; 577 are open to participants now.

This study's enrollment of 20 is below the median of 40 across 2,649 interventional studies indexed under Diabetes Mellitus, Type 1.

Browse Diabetes Mellitus, Type 1 studies →

Lead sponsor

Diabeteszentrum Bad Lauterberg im Harz is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Type 1 diabetes
  • Basal insulin substitution with insulin glargine at least 3 month

Exclusion criteria

Exclusion Criteria:

  • Severe disorders
  • Severe and clinical significant gastroparesis
  • History of pancreatitis or pancreatic cancer
  • Severe Liver disorder (liver enzymes > three times upper normal limit)
  • Pregnancy
  • Drug- or alcohol abuse
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Other
    With late night snack

    At 10 p.m. a late night snack (one slice of whole meal rye bread containing approximately 20 g of carbohydrate) was eaten from Type 1 diabetic patients on an intensified conventional treatment regimen.

    Dietary Supplement: Late night snack

  • Other
    Without late night snack

    Not nutrients (No late night snack) were consumed at 10 p.m. from Type 1 diabetic patients on an intensified conventional treatment regimen..

    Other: No late night snack

Interventions

  • Dietary supplementLate night snack

    The late night snack was one slice of whole meal rye bread containing approximately 20 g of carbohydrate.

  • OtherNo late night snack

    Patient consumed no nutrients at late night.

06

What researchers measure

Primary outcomes

  1. Hypoglycemia

    Hypoglycemia with a plasma glucose ≤ 50 mg/dl as determined with a standardized laboratory method

    Time frame: 26 hours

Secondary outcomes

  1. Blood glucose profile

    The blood glucose profile with and without a late-night snack . (standard blood glucose profiles with determinations at 6, 8, and 10 p.m, at midnight, at 2, 4, 6:45, 8:45 a.m., and at noon and 2, 6, and 8 p.m. of the following day).

    Time frame: 26 hours

07

Study locations

1 site
  • Diabeteszentrum Bad Lauterberg
    Bad Lauterberg, Niedersachsen 37431, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 18, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02871180
Lead sponsor
Diabeteszentrum Bad Lauterberg im Harz
Responsible party
Michael A. Nauck (Prof. Dr. med. Michael A. Nauck, Diabeteszentrum Bad Lauterberg im Harz) — Principal investigator
First posted
Aug 18, 2016
Start date
Mar 2003
Primary completion
Aug 2016
Last update
Aug 18, 2016

Study contacts

Michael A. Nauck, Prof.
principal investigator · St. Josef-Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion